Om Silakari

发表

Investigating the Role of Missense SNPs on ALDH 1A1 mediated pharmacokinetic resistance to cyclophosphamide

Himanshu Verma, Om Silakari, O. Silakari, 2020, Comput. Biol. Medicine.

Exploring the Role of Water Molecules for Docking and Receptor Guided 3D-QSAR Analysis of Naphthyridine Derivatives as Spleen Tyrosine Kinase (Syk) Inhibitors

Maninder Kaur, Om Silakari, Malkeet Singh Bahia, 2012, J. Chem. Inf. Model..

Significance of Molecular Surfaces and Different Visualization Tools in Drug Designing

Himanshu Verma, Om Silakari, Shalki Choudhary, 2019, International Journal of Quantitative Structure-Property Relationships.

Multitargeting Heterocycles: Improved and Rational Chemical Probes for Multifactorial Diseases

Om Silakari, Pankaj Kumar Singh, 2018 .

Putative dual inhibitors of Janus kinase 1 and 3 (JAK1/3): Pharmacophore based hierarchical virtual screening

Maninder Kaur, Om Silakari, Malkeet Singh Bahia, 2018, Comput. Biol. Chem..

Database exploration: Selection and analysis of target protein structures

Om Silakari, Pankaj Kumar Singh, P. Singh, 2021 .

Scaffold hopping: An approach to improve the existing pharmacological profile of NCEs

Om Silakari, Pankaj Kumar Singh, P. Singh, 2021 .

Molecular docking analysis: Basic technique to predict drug-receptor interactions

Om Silakari, Pankaj Kumar Singh, P. Singh, 2021 .

Homology modeling: Developing 3D structures of target proteins missing in databases

Om Silakari, Pankaj Kumar Singh, P. Singh, 2021, Concepts and Experimental Protocols of Modelling and Informatics in Drug Design.

Ligand-based pharmacophore modeling: A technique utilized for virtual screening of commercial databases

Om Silakari, Pankaj Kumar Singh, 2021, Concepts and Experimental Protocols of Modelling and Informatics in Drug Design.

QSAR: Descriptor calculations, model generation, validation and their application

Om Silakari, Pankaj Kumar Singh, 2021 .

Statistical methods and parameters: Tools to generate and evaluate theoretical in silico models

Om Silakari, Pankaj Kumar Singh, P. Singh, 2021 .

Small molecule databases: A collection of promising bioactive molecules

Om Silakari, Pankaj Kumar Singh, P. Singh, 2021 .

Cheminformatic tools: Identify suitable synthesis procedures to realize designed molecules

Om Silakari, Pankaj Kumar Singh, 2021 .

Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it

Om Silakari, Shalki Choudhary, Pankaj Kumar Singh, 2019, Drug metabolism reviews.

Three dimensional pharmacophore modelling for c-Kit receptor tyrosine kinase inhibitors.

Om Silakari, Neha Kansal, O. Silakari, 2010, European journal of medicinal chemistry.

Molecular dynamics/quantum mechanics guided designing of natural products based prodrugs of Epalrestat

Renu Bahadur, Manjinder Singh, Harpreet Singh, 2018, Journal of Molecular Structure.

Counting on Fragment Based Drug Design Approach for Drug Discovery.

Om Silakari, Pankaj Kumar Singh, P. Singh, 2019, Current topics in medicinal chemistry.

Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore- and docking-based virtual screening approach

Om Silakari, Haneesh Jasuja, Navriti Chadha, 2013, Molecular Diversity.

Elaboration of New Anti-Inflammatory Agents Using Pharmacophore Based 3D QSAR of 4, 5-Diaryl Imidazoline as P2X7 Receptor Antagonists

Om Silakari, Malkeet Singh Bahia, Nisha Mehta, 2012 .

Decoding the signature of molecular mechanism involved in mutation associated resistance to 1, 3-benzothiazin-4-ones (Btzs) based DprE1 inhibitors using BTZ043 as a reference drug

Om Silakari, Pankaj Kumar Singh, Shalki Choudhary, 2019, Molecular Simulation.

Acetylcholinesterase Inhibitors as Alzheimer Therapy: From Nerve Toxins to Neuroprotection

Manjinder Singh, Om Silakari, Manjinder Singh, 2014 .

Multifunctional compounds: smart molecules for multifactorial diseases.

Om Silakari, Y. Bansal, O. Silakari, 2014, European journal of medicinal chemistry.

A Three Dimensional Pharmacophore Modeling for KDR and Tie‐2 Receptor Tyrosine Kinase Inhibitors and Virtual Screening for New Multikinase Inhibitors

Om Silakari, Neha Kansal, O. Silakari, 2009 .

Exploration of the therapeutic aspects of Lck: A kinase target in inflammatory mediated pathological conditions.

Om Silakari, Pankaj Kumar Singh, O. Silakari, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.